Nanometric photodiodes can activate individual nerve cells August 15, 2022 -- Italian researchers activated individual nerve cells with a light impulse and this targeted, noninvasive approach could be used for studies into the nervous system as well as to develop new therapies.Read More
Timothy Hunt to take helm of ARM as new CEO August 11, 2022 -- The Alliance for Regenerative Medicine (ARM) has announced that Timothy Hunt will succeed Janet Lambert as chief executive officer (CEO) of the Washington, DC-based advocacy organization, which represents the cell and gene therapy industry.Read More
Now metastasis can be observed with an assay August 15, 2022 -- University College Dublin researchers have provided a new mechanism for observing cell migration with a high-throughput spheroid-based migration assay. The assay uses a tissue-mimicking, fibrillar collagen type I extracellular matrix.Read More
Monocytes, not neutrophils, are key to skin wound repair August 15, 2022 -- New research reveals monocytes alone are capable of facilitating faster healing of skin wounds, which runs counter to previous beliefs that neutrophils and monocytes both performed that function.Read More
Video from AACC: AACC president on Theranos, VALID Act August 1, 2022 -- Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo held this week in Chicago.Read More
New drug heals nervous system damage from stroke August 1, 2022 -- A new drug can repair nervous system damage caused by a stroke, at least in animal studies. In a preclinical study, researchers from the University of Cincinnati and Case Western Reserve University have found that one drug resulted in significant improvement in motor function, sensory function, spatial learning, and memory.Read More
Seer debuts new proteomic-mapping software August 3, 2022 -- Seer has launched a new Proteogenomics Workflow that integrates deep proteomics with genomics and is powered by the Proteograph Analysis Suite 2.0.Read More
Video from AACC: Enzo BioChem CEO on COVID-19 test landscape August 1, 2022 -- Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the in vitro diagnostics landscape as the COVID-19 pandemic evolves.Read More